In This Section
Ross L. Levine, MD

Ross L. Levine, MD

Memorial Sloan Kettering Cancer Center
New York, New York

Class of 2026

For groundbreaking contributions to characterizing the molecular biology of clonal hematopoiesis and myeloid malignancies, including discovering key driver mutations, delineating the role of signaling pathways such as the JAK-STAT pathway in oncogenesis, and investigating epigenetic mechanisms that influence myeloproliferative neoplasm (MPN) and acute myeloid leukemia (AML) progression.

*Full-length biography in development

[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]